SCHEDULE 13G//SEC Filing
Lyell Immunopharma, Inc. SCHEDULE 13G
Accession 0001415889-25-022288
CIK 0002082302other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:10 PM ET
Size
15.4 KB
Accession
0001415889-25-022288
Issuer
Explore Investments LLC/DE
CIK 0002082302
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002082302
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:10 PM ET
- Size
- 15.4 KB